https://biotechdispatch.com.au/news/immutep-advances-imp761-manufacturing-with-new-agreement
Immutep advances IMP761 manufacturing with new agreement - Biotech
Immunotherapy development company Immutep (ASX:IMM) has signed a Manufacturing Service Agreement with Northway Biotech.
advancesmanufacturingnewagreementbiotech